New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins

This book review series presents current trends in modern biotechnology. The aim is to cover all aspects of this interdisciplinary technology where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science. Volumes a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Kiss, Bob (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Gottschalk, Uwe (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Pohlscheidt, Michael (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Σειρά:Advances in Biochemical Engineering/Biotechnology, 165
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04370nam a2200517 4500
001 978-3-319-97110-0
003 DE-He213
005 20191028213739.0
007 cr nn 008mamaa
008 181206s2018 gw | s |||| 0|eng d
020 |a 9783319971100  |9 978-3-319-97110-0 
024 7 |a 10.1007/978-3-319-97110-0  |2 doi 
040 |d GrThAP 
050 4 |a TP248.13-248.65 
072 7 |a TCB  |2 bicssc 
072 7 |a SCI010000  |2 bisacsh 
072 7 |a TCB  |2 thema 
082 0 4 |a 660.6  |2 23 
245 1 0 |a New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins  |h [electronic resource] /  |c edited by Bob Kiss, Uwe Gottschalk, Michael Pohlscheidt. 
250 |a 1st ed. 2018. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2018. 
300 |a VI, 469 p. 70 illus., 54 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Biochemical Engineering/Biotechnology,  |x 0724-6145 ;  |v 165 
505 0 |a Market and Capacity evolvement of the Biopharmaceutical Industry -- New Mammalian Expression Systems -- Innovation in seed train cultivation and production culture -- Manufacturing of Proteins and Antibodies / Risk mitigation for the contamination by adventitious agents -- Harvest operations -- Downstream Processing Technologies / Capturing and Final Purifaction -- Fully disposable manufacturing concepts for clinical and commercial manufacturing and Ballroom Concepts -- Augmented Reality - PAT and Artificial Intelligence for innovative process monitoring and controls -- Trends and innovations in formulations, fill and finish technologies and drug delivery -- Process Integration towards continuous manufacturing -- Future direction of Manufacturing of novel molecular format - a research perspective (bispecific antibodies, ADC, Ab fragments, fusion proteins, etc -- Cell therapy manufacturing for modern therapeutics -- Gene therapy -- Modern technologies and strategies for vaccine manufacturing -- Product and Technology Lifecycle Management in the Pharmaceutical Industry -- Integrated High Throughput Development -- A different perspective - How much innovation is really needed for production of mAb by mammalian cell technology? 
520 |a This book review series presents current trends in modern biotechnology. The aim is to cover all aspects of this interdisciplinary technology where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science. Volumes are organized topically and provide a comprehensive discussion of developments in the respective field over the past 3-5 years. The series also discusses new discoveries and applications. Special volumes are dedicated to selected topics which focus on new biotechnological products and new processes for their synthesis and purification. In general, special volumes are edited by well-known guest editors. The series editor and publisher will however always be pleased to receive suggestions and supplementary information. Manuscripts are accepted in English. 
650 0 |a Biotechnology. 
650 0 |a Pharmaceutical technology. 
650 0 |a Medicinal chemistry. 
650 1 4 |a Biotechnology.  |0 http://scigraph.springernature.com/things/product-market-codes/C12002 
650 2 4 |a Pharmaceutical Sciences/Technology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21010 
650 2 4 |a Medicinal Chemistry.  |0 http://scigraph.springernature.com/things/product-market-codes/C28000 
700 1 |a Kiss, Bob.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Gottschalk, Uwe.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Pohlscheidt, Michael.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319971087 
776 0 8 |i Printed edition:  |z 9783319971094 
830 0 |a Advances in Biochemical Engineering/Biotechnology,  |x 0724-6145 ;  |v 165 
856 4 0 |u https://doi.org/10.1007/978-3-319-97110-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-CMS 
950 |a Chemistry and Materials Science (Springer-11644)